Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
Verdant builds AI-powered Smart Sprayers that weed, thin, fertilize & deliver nutrients at millimeter level.
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
MycoWorks is a biotechnology company that offers non-plastic and non-animal materials to the market.
Estes Energy is a California-based startup developing advanced, U.S.-made, chemistry-agnostic battery packs for mobility and industry.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Stemson Therapeutics is a pre-clinical stage cell therapy company.
Sabanto provides a Farming-as-a-Service tool that transforms existing tractors into fully autonomous machines.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.
Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.
AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges.
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.
AgZen develops pesticide sprays stick to plants which reduces pollution and helps farmers save.
Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.
Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
Valar Labs offers assistance services for cancer treatment through Artificial Intelligence.
Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.
DCVC Bio has invested in 56 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
DCVC Bio's top investment sectors include Biotechnology, Therapeutics, Medical, Life Science, Manufacturing. The firm invests across 30 different industry categories.
Among tracked funding rounds, AbCellera received $515.8M in a Grant round. DCVC Bio's total known invested capital is $2.5B.
DCVC Bio's average investment size is $61.8M across its portfolio of 56 companies.
Recent DCVC Bio portfolio additions include Novome Biotechnologies, Verdant Robotics, Inc., Plexium, Alchemab Therapeutics, MycoWorks. These companies were founded in 2020 or later.